Physician

Benjamin Fusman, M.D.

According to 2025 Medicare claims, Benjamin Fusman, M.D. (NPI: 1376540351) practices interventional cardiology in the Newark, NJ market, with the plurality of this provider's patient population coming from Morris, NJ. This provider's primary affiliated billing organization is PRACTICE ASSOCIATES MEDICAL GROUP (NPI: 1427016385; TIN: 202088165) and primary practice location at 07046-1717. Fusman is affiliated with the Atlantic ACO (ACO ID: A1026), participating under the MSSP model.

Fusman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,674 traditional Medicare patients, billed 5,547 HCPCS/CPT codes, and received $321,894 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 9,554 prescription claims across 917 beneficiaries totaling $1,936,603 in drug costs, led by Eliquis (Apixaban). 2015 DME data shows 62 claims. Open Payments data shows 29 records totaling $396. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $314,703 to $1,936,603. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $2,660 to $5,875.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,133	4,552	$324,364
2016	1,101	4,613	$308,033
2017	1,100	4,497	$296,293
2018	1,015	4,752	$321,667
2019	1,115	4,528	$304,335
2020	1,173	4,251	$288,876
2021	1,151	4,611	$339,959
2022	1,130	4,656	$323,612
2023	1,614	5,244	$310,180
2024	1,674	5,547	$321,894

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	385	4,445	$314,703
2016	426	5,025	$421,650
2017	465	5,373	$418,704
2018	493	5,796	$547,476
2019	576	6,615	$748,506
2020	670	7,499	$966,154
2021	729	7,978	$1,113,512
2022	818	8,630	$1,416,354
2023	877	9,350	$1,852,546
2024	917	9,554	$1,936,603

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	62	$2,574
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	208	506	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	591	1,350	$98
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	363	374	$54
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	588	1,119	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	755	952	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	545	37,293	$708,444
Entresto	Sacubitril/Valsartan	142	9,476	$206,278
Farxiga	Dapagliflozin Propanediol	142	9,660	$175,781
Xarelto	Rivaroxaban	120	9,705	$175,756
Repatha Sureclick	Evolocumab	105	6,723	$126,540

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$396	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Benjamin Fusman, M.D.?

Tedicare shows public-source Medicare data for Benjamin Fusman, M.D. (NPI 1376540351), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin Fusman, M.D. have ACO affiliation data?

Benjamin Fusman, M.D. is shown with ACO affiliation data for Atlantic ACO (MSSP, ACO ID A1026).

What billing organization is linked to Benjamin Fusman, M.D.?

Benjamin Fusman, M.D. is linked to PRACTICE ASSOCIATES MEDICAL GROUP (billing NPI 1427016385) in the available physician profile data.

Does Benjamin Fusman, M.D. have Open Payments data?

Benjamin Fusman, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.